Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Joint attention behavior refers to the shared focus of two individuals on an object, event, or topic, enabled by coordinated gaze, gestures, or verbal cues[1][2][3]. It is a foundational developmental skill, first emerging in infancy, critical for effective social communication, language acquisition, and theory of mind[1][2][3][4][6]. Deficits in joint attention are recognized as core features of autism spectrum disorder and other neurodevelopmental conditions[4][6]. The ability to initiate and respond to joint attention bids underlies early learning, social bonding, and cognitive growth[2][3][6]. Joint attention is studied behaviorally and neurologically but is not a molecule, gene, protein, receptor, or other typical therapeutic target[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Joint attention behavior.